Surgical Oncology
Volume 18, Issue 4 , Pages 357-365 , December 2009

Loss of Bcl-2 expression in colon cancer: A prognostic factor for recurrence in stage II colon cancer

  • Laurent Poincloux

      Affiliations

    • Department of Gastroenterology CHRU, Hotel-Dieu, avenue Vercingetorix, 63000 Clermont-Ferrand, France
    • Department of Digestive Oncology, Institut Paoli Calmettes, 232 boulevard Sainte Marguerite, Marseille, France
    • Corresponding Author InformationCorresponding author. Department of Gastroenterology CHRU, Hotel-Dieu, avenue Vercingetorix, 63000 Clermont-Ferrand, France. Tel.: +33 4 73 75 05 44; fax: +33 4 73 75 05 07.
    • ,
  • Xavier Durando

      Affiliations

    • Clinical Research Unit, Centre Jean Perrin, 58 rue Montalembert, 63011 Clermont-Ferrand, France
    • ,
  • Jean François Seitz

      Affiliations

    • Department of Digestive Oncology, Institut Paoli Calmettes, 232 boulevard Sainte Marguerite, Marseille, France
    • ,
  • Emilie Thivat

      Affiliations

    • Clinical Research Unit, Centre Jean Perrin, 58 rue Montalembert, 63011 Clermont-Ferrand, France
    • ,
  • Valérie-Jeanne Bardou

      Affiliations

    • Department of Biostatistics, Institut Paoli Calmettes, 232 boulevard Sainte Marguerite, Marseille, France
    • ,
  • Marie-Hélène Giovannini

      Affiliations

    • Department of Biostatistics, Institut Paoli Calmettes, 232 boulevard Sainte Marguerite, Marseille, France
    • ,
  • Danièle Parriaux

      Affiliations

    • Department of Pathology, Institut Paoli Calmettes, 232 boulevard Sainte Marguerite, Marseille, France
    • ,
  • Nicolas Barriere

      Affiliations

    • Department of Digestive Oncology, Institut Paoli Calmettes, 232 boulevard Sainte Marguerite, Marseille, France
    • ,
  • Marc Giovannini

      Affiliations

    • Department of Digestive Oncology, Institut Paoli Calmettes, 232 boulevard Sainte Marguerite, Marseille, France
    • ,
  • Jean-Robert Delpero

      Affiliations

    • Department of Digestive Oncology, Institut Paoli Calmettes, 232 boulevard Sainte Marguerite, Marseille, France
    • ,
  • Geneviève Monges

      Affiliations

    • Department of Pathology, Institut Paoli Calmettes, 232 boulevard Sainte Marguerite, Marseille, France

,Accepted 27 September 2008.

References 

  1. Remontet L, Estève J, Bouvier AM, Grosclaude P, Launoy G, Menegoz F, et al. Cancer incidence and mortality in France over the period 1978-2000. Rev Epidemiol Sante Publique. 2003;51:3–30
  2. O'Connell JB, Maggard MA, Ko CY. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst. 2004;96:1420–1425
  3. Cianchi F, Balzi M, Becciolini A, Giache V, Messerini L, Palomba A, et al. DNA ploidy, cell proliferation and genetic alterations in colorectal cancer: correlation with clinicopathological features. Biomed Pharmacother. 1996;50:418
  4. Manne U, Myers RB, Moron C, Poczatek RB, Dillard S. Weiss, et al. Prognostic significance of Bcl-2 expression and p53 nuclear accumulation in colorectal adenocarcinoma. Int J Cancer. 1997;74(3):346–358
  5. Buglioni S, D'Agnano I, Cosimelli M, Vasselli S, D'Angelo C, Tedesco M, et al. Evaluation of multiple bio-pathological factors in colorectal adenocarcinomas: independent prognostic role of p53 and bcl-2. Int J Cancer. 1999;84:545–552
  6. Ilyas M, Hao XP, Wilkinson K, Tomlinson IP, Abbasi AM, Forbes A, et al. Loss of Bcl-2 expression correlates with tumour recurrence in colorectal cancer. Gut. 1998;43:383–387
  7. Sinicrope FA, Hart J, Michelassi F, Lee JJ. Prognostic value of bcl-2 oncoprotein expression in stage II colon carcinoma. Clin Cancer Res. 1995;1:1103–1110
  8. Heinimann K, Müller H, Dobbie Z. Microsatellite instability in colorectal cancer. N Engl J Med. 2000;342:1607–1608
  9. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, et al. Genetic alterations during colorectal-tumor development. N Engl J Med. 1988;319:525–532
  10. Stewart BW. Mechanisms of apoptosis: integration of genetic, biochemical, and cellular indicators. J Natl Cancer Inst. 1994;86:1286–1296
  11. Sturm I, Köhne CH, Wolff G, Petrowsky H, Hillebrand T, Hauptmann S, et al. Analysis of the p53/BAX pathway in colorectal cancer: low BAX is a negative prognostic factor in patients with resected liver metastases. J Clin Oncol. 1999;17(5):1364–1374
  12. Krajewski S, Tanaka S, Takayama S, Schibler MJ, Fenton W, Reed JC. Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. Cancer Res. 1993;53:4701–4714
  13. Sinicrope FA, Ruan SB, Cleary KR, Stephens LC, Lee JJ. Levin B.bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Res. 1995;55:237–241
  14. Bronner MP, Culin C, Reed JC, Furth EE. The bcl-2 proto-oncogene and the gastrointestinal epithelial tumor progression model. Am J Pathol. 1995;146:20–26
  15. Huerta S, Goulet EJ, Livingston EH. Colon cancer and apoptosis. Am J Surg. 2006;191:517–526Review
  16. Ofner D, Riehemann K, Maier H, Riedmann B, Nehoda H, Tötsch M, et al. Immunohistochemically detectable bcl-2 expression in colorectal carcinoma: correlation with tumour stage and patient survival. Br J Cancer. 1995 Oct;72(4):981–985
  17. Bosari S, Moneghini L, Graziani D, Lee AK, Murray JJ, Coggi G, et al. bcl-2 oncoprotein in colorectal hyperplastic polyps, adenomas, and adenocarcinomas. Hum Pathol. 1995;26:534–540
  18. Giatromanolaki A, Sivridis E, Stathopoulos GP, Fountzilas G, Kalofonos HP, Tsamandas A, et al. Bax protein expression in colorectal cancer: association with p53, bcl-2 and patterns of relapse. Anticancer Res. 2001;21:253–259
  19. Leahy DT, Mulcahy HE, O'Donoghue DP, Parfrey NA. bcl-2 protein expression is associated with better prognosis in colorectal cancer. Histopathology. 1999;35:360–367
  20. Torsello A, Garufi C, Cosimelli M, Diodoro MG, Zeuli M, Vanni B, et al. on behalf of the Colorectal Disease Management Team, Regina Elena Cancer Institute, Rome, Italy. P53 and bcl-2 in colorectal cancer arising in patients under 40 years of age: Distribution and prognostic relevance. Eur J Cancer. 2008;44:1217–1222
  21. Tollenaar RA, van Krieken JH, van Slooten HJ, Bruinvels DJ, Nelemans KM, van den Broek LJ, et al. Immunohistochemical detection of p53 and Bcl-2 in colorectal carcinoma: no evidence for prognostic significance. Br J Cancer. 1998;77:1842–1847
  22. Baretton GB, Diebold J, Christoforis G, Vogt M, Müller C, Dopfer K, et al. Apoptosis and immunohistochemical bcl-2 expression in colorectal adenomas and carcinomas. Aspects of carcinogenesis and prognostic significance. Cancer. 1996;77:255–264
  23. Kaklamanis L, Savage A, Whitehouse R, Doussis-Anagnostopoulou I, Biddolph S, Tsiotos P, et al. Bcl-2 protein expression: association with p53 and prognosis in colorectal cancer. Br J Cancer. 1998;77:1864–1869
  24. Schneider HJ, Sampson SA, Cunningham D, Norman AR, Andreyev HJ, Tilsed JV, et al. Bcl-2 expression and response to chemotherapy in colorectal adenocarcinomas. Br J Cancer. 1997;75:427–431
  25. Mander BJ, Carney LJ, Scott HJ, Donaldson DR. Jass staging is a predictor of outcome following “curative” resection of Dukes’ B colorectal carcinoma. Surgeon. 2006;4:227–230
  26. Chatla C, Jhala NC, Katkoori VR, Alexander D, Meleth S, Grizzle WE, et al. Recurrence and survival predictive value of phenotypic expression of Bcl-2 varies with tumor stage of colorectal adenocarcinoma. Cancer Biomark. 2005;1:241–250
  27. Pereira H, Silva S, Julião R, Garcia P, Perpétua F. Prognostic markers for colorectal cancer: expression of P53 and BCL2. World J Surg. 1997;21:210–213
  28. Berney CR, Downing SR, Yang JL, Russell PJ, Crowe PJ. Evidence for post-transcriptional down-regulation of the apoptosis-related gene bcl-2 in human colorectal cancer. J Pathol. 2000;191:15–20
  29. Yang HB, Chow NH, Sheu BS, Chan SH, Chien CH, Su IJ. The role of bcl-2 in the progression of the colorectal adenoma-carcinoma sequence. Anticancer Res. 1999;19:727–730
  30. Saleh HA, Jackson H, Khatib G, Banerjee M. Correlation of bcl-2 oncoprotein immunohistochemical expression with proliferation index and histopathologic parameters in colorectal neoplasia. Pathol Oncol Res. 1999;5:273–279

PII: S0960-7404(08)00101-1

doi: 10.1016/j.suronc.2008.09.003

Surgical Oncology
Volume 18, Issue 4 , Pages 357-365 , December 2009

Article Tools